$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

$sbra Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-Q Financial Statement

#000149229815000017 Filed on May 06, 2015

Income Statement

Concept	2015 Q1	2014 Q1
Revenue	$55.57M	$40.85M
YoY Change	36.04%	27.57%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$8.000M	$5.900M
YoY Change	35.59%	25.53%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$14.15M	$9.350M
YoY Change	51.34%	13.39%
% of Gross Profit
Operating Expenses	$22.10M	$15.30M
YoY Change	44.44%	22.4%
Operating Profit
YoY Change
Interest Expense	-$13.90M	-$11.10M
YoY Change	25.23%	11.0%
% of Operating Profit
Other Income/Expense, Net	-$100.0K	$300.0K
YoY Change	-133.33%
Pretax Income	$19.40M	-$7.300M
YoY Change	-365.75%	-176.04%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	$19.45M	-$7.303M
YoY Change	-366.33%	-176.42%
Net Earnings / Revenue	35.0%	-17.88%
Basic Earnings Per Share	$0.29	-$0.25
Diluted Earnings Per Share	$0.28	-$0.25
COMMON SHARES
Basic Shares Outstanding	59.19M shares	38.97M shares
Diluted Shares Outstanding	59.56M shares	38.97M shares

Balance Sheet

Concept	2015 Q1	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.200M	$4.300M
YoY Change	-2.33%	-91.98%
Cash & Equivalents	$4.171M	$4.286M
Short-Term Investments
Other Short-Term Assets	$102.3M	$75.20M
YoY Change	36.04%	100.53%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$106.5M	$79.50M
YoY Change	33.96%	-12.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.633B	$1.022B
YoY Change	59.8%	24.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.900M	$30.60M
YoY Change	-77.45%	3.73%
Total Long-Term Assets	$1.898B	$1.252B
YoY Change	51.61%	43.32%
TOTAL ASSETS
Total Short-Term Assets	$106.5M	$79.50M
Total Long-Term Assets	$1.898B	$1.252B
Total Assets	$2.004B	$1.331B
YoY Change	50.56%	38.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$23.70M	$26.30M
YoY Change	-9.89%	42.93%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$23.70M	$50.50M
YoY Change	-53.07%	18.54%
LONG-TERM LIABILITIES
Long-Term Debt	$1.049B	$842.1M
YoY Change	24.52%	74.78%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$1.049B	$842.1M
YoY Change	24.52%	74.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.70M	$50.50M
Total Long-Term Liabilities	$1.049B	$842.1M
Total Liabilities	$1.072B	$892.6M
YoY Change	20.13%	70.21%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$592.0K	$391.0K
YoY Change	51.41%	4.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$932.2M	$438.7M
YoY Change
Total Liabilities & Shareholders Equity	$2.004B	$1.331B
YoY Change	50.56%	38.03%

Cashflow Statement

Concept	2015 Q1	2014 Q1
OPERATING ACTIVITIES
Net Income	$19.45M	-$7.303M
YoY Change	-366.33%	-176.42%
Depreciation, Depletion And Amortization	$14.15M	$9.350M
YoY Change	51.34%	13.39%
Cash From Operating Activities	$24.70M	$1.207M
YoY Change	1946.48%	-94.41%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$108.7M
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$6.200M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$6.237M	-$128.1M
YoY Change	-95.13%	736.91%
FINANCING ACTIVITIES
Cash Dividend Paid	$25.67M	$16.60M
YoY Change	54.68%	30.52%
Common Stock Issuance & Retirement, Net	-$7.587M	-$648.0K
YoY Change	1070.83%	-74.43%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$76.09M	$126.9M
YoY Change	-159.95%	320.62%
NET CHANGE
Cash From Operating Activities	$24.70M	$1.207M
Cash From Investing Activities	-$6.237M	-$128.1M
Cash From Financing Activities	-$76.09M	$126.9M
Net Change In Cash	-$57.62M	-$22.00K
YoY Change	261818.18%	-100.06%
FREE CASH FLOW
Cash From Operating Activities	$24.70M	$1.207M
Capital Expenditures	$0.00	-$108.7M
Free Cash Flow	$24.70M	$109.9M
YoY Change	-77.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001492298
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	59234056	shares
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	Sabra Health Care REIT, Inc.
CY2014Q1	sbra	Business Combination Contingent Consideration Changein Fair Valueof Liability BusinessCombinationContingentConsiderationChangeinFairValueofLiability	300000	USD
CY2015Q1	sbra	Business Combination Contingent Consideration Changein Fair Valueof Liability BusinessCombinationContingentConsiderationChangeinFairValueofLiability	-100000	USD
CY2014Q4	sbra	Common Stock Atthe Market Stock Offering Sales Commission CommonStockAttheMarketStockOfferingSalesCommission	0.02
CY2015Q1	sbra	Contingent Consideration Fair Value Disclosure ContingentConsiderationFairValueDisclosure	4000000	USD
CY2015Q1	sbra	Convertible Preferred Stock Conversion Price ConvertiblePreferredStockConversionPrice	25.00
CY2015Q1	sbra	Derivative Instrument Effecton Fair Value Decreaseof100 Basis Pointsin Interest Rates DerivativeInstrumentEffectonFairValueDecreaseof100BasisPointsinInterestRates	2522000	USD
CY2015Q1	sbra	Derivative Instrument Effecton Fair Value Decreaseof50 Basis Pointsin Interest Rates DerivativeInstrumentEffectonFairValueDecreaseof50BasisPointsinInterestRates	1511000	USD
CY2015Q1	sbra	Derivative Instrument Effecton Fair Value Increaseof100 Basis Pointsin Interest Rates DerivativeInstrumentEffectonFairValueIncreaseof100BasisPointsinInterestRates	4284000	USD
CY2015Q1	sbra	Derivative Instrument Effecton Fair Value Increaseof50 Basis Pointsin Interest Rates DerivativeInstrumentEffectonFairValueIncreaseof50BasisPointsinInterestRates	1947000	USD
CY2014Q1	sbra	Gain Loss On Extinguishment Of Debt Noncash Portion GainLossOnExtinguishmentOfDebtNoncashPortion	-1338000	USD
CY2015Q1	sbra	Gain Loss On Extinguishment Of Debt Noncash Portion GainLossOnExtinguishmentOfDebtNoncashPortion	0	USD
CY2014Q1	sbra	Income Loss From Subsidiaries IncomeLossFromSubsidiaries	0	USD
CY2015Q1	sbra	Income Loss From Subsidiaries IncomeLossFromSubsidiaries	0	USD
CY2014Q1	sbra	Interest Income InterestIncome	4757000	USD
CY2015Q1	sbra	Interest Income InterestIncome	6067000	USD
CY2015Q1	sbra	Investments Weighted Average Contractual Rate InvestmentsWeightedAverageContractualRate	0.087
CY2015Q1	sbra	Investments Weighted Average Effective Rate InvestmentsWeightedAverageEffectiveRate	0.085
CY2014Q4	sbra	Loan Receivable Face Value LoanReceivableFaceValue	234359000	USD
CY2015Q1	sbra	Loan Receivable Face Value LoanReceivableFaceValue	240363000	USD
CY2015Q1	sbra	Loans And Leases Receivable Effective Interest Rate LoansAndLeasesReceivableEffectiveInterestRate	0.082
CY2015Q1	sbra	Loans And Leases Receivable Fixed Interest Rate LoansAndLeasesReceivableFixedInterestRate	0.084
CY2015Q1	sbra	Loans And Leases Receivable Number Of Loans LoansAndLeasesReceivableNumberOfLoans	14	loan
CY2014Q4	sbra	Loansreceivableandotherinvestmentsnet Loansreceivableandotherinvestmentsnet	251583000	USD
CY2015Q1	sbra	Loansreceivableandotherinvestmentsnet Loansreceivableandotherinvestmentsnet	258346000	USD
CY2015Q1	sbra	Numberof Investments NumberofInvestments	20	loan
CY2015Q1	sbra	Operating Leases Weighted Average Lease Expiration Period OperatingLeasesWeightedAverageLeaseExpirationPeriod	P10Y
CY2014Q1	sbra	Payments For Proceeds From Intercompany Financing Investing Activities PaymentsForProceedsFromIntercompanyFinancingInvestingActivities	0	USD
CY2015Q1	sbra	Payments For Proceeds From Intercompany Financing Investing Activities PaymentsForProceedsFromIntercompanyFinancingInvestingActivities	0	USD
CY2015Q1	sbra	Payments Of Distributions To Parent PaymentsOfDistributionsToParent	0	USD
CY2014Q4	sbra	Preferred Equity Investment Carrying Amount PreferredEquityInvestmentCarryingAmount	16407000	USD
CY2015Q1	sbra	Preferred Equity Investment Carrying Amount PreferredEquityInvestmentCarryingAmount	17214000	USD
CY2014Q4	sbra	Preferred Equity Investment Face Value PreferredEquityInvestmentFaceValue	16125000	USD
CY2015Q1	sbra	Preferred Equity Investment Face Value PreferredEquityInvestmentFaceValue	16919000	USD
CY2015Q1	sbra	Preferred Equity Investment Weighted Average Contractual Rate PreferredEquityInvestmentWeightedAverageContractualRate	0.125
CY2015Q1	sbra	Preferred Equity Investment Weighted Average Effective Rate PreferredEquityInvestmentWeightedAverageEffectiveRate	0.125
CY2015Q1	sbra	Preferred Equity Investments Number PreferredEquityInvestmentsNumber	6	loan
CY2014Q4	sbra	Prepaid Expenses Deferred Financing Costs And Other Assets PrepaidExpensesDeferredFinancingCostsAndOtherAssets	98687000	USD
CY2015Q1	sbra	Prepaid Expenses Deferred Financing Costs And Other Assets PrepaidExpensesDeferredFinancingCostsAndOtherAssets	102325000	USD
CY2015Q1	sbra	Proceeds From Distributions To Parent Investing Activities ProceedsFromDistributionsToParentInvestingActivities	0	USD
CY2014Q2	sbra	Stock Issued During Period Shares New Issues Underwriters Option StockIssuedDuringPeriodSharesNewIssuesUnderwritersOption	1100000	shares
CY2014Q4	sbra	Stock Issued During Period Shares New Issues Underwriters Option StockIssuedDuringPeriodSharesNewIssuesUnderwritersOption	900000	shares
CY2014Q1	sbra	Total Expenses TotalExpenses	26337000	USD
CY2015Q1	sbra	Total Expenses TotalExpenses	36033000	USD
CY2014Q1	sbra	Total Other Income Expense TotalOtherIncomeExpense	-21834000	USD
CY2015Q1	sbra	Total Other Income Expense TotalOtherIncomeExpense	-100000	USD
CY2014Q1	sbra	Writeoffofstraightlinerentalincome Writeoffofstraightlinerentalincome	99000	USD
CY2015Q1	sbra	Writeoffofstraightlinerentalincome Writeoffofstraightlinerentalincome	0	USD
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	31775000	USD
CY2015Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	23720000	USD
CY2014Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	110841000	USD
CY2015Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	117168000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1542000	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3087000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1053601000	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1051813000	USD
CY2014Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2689000	USD
CY2015Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3023000	USD
CY2014Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-33000	USD
CY2015Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	25000	USD
CY2014Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	945000	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1261000	USD
CY2014Q4	us-gaap	Assets Assets	2064892000	USD
CY2015Q1	us-gaap	Assets Assets	2004497000	USD
CY2014Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1551548000	USD
CY2015Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1552220000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4308000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4286000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61793000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4171000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-22000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-57622000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.39
CY2014Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.36
CY2015Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.39
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59047001	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59234056	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59047001	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59234056	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	590000	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	592000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7303000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17905000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-18000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-11000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-7321000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	17894000	USD
CY2015Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1.7864	shares
CY2014Q1	us-gaap	Debtor Reorganization Items Write Off Of Deferred Financing Costs And Debt Discounts DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts	500000	USD
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9350000	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14150000	USD
CY2014Q4	us-gaap	Derivative Cost Of Hedge DerivativeCostOfHedge	6200000	USD
CY2014Q1	us-gaap	Dividends Common Stock DividendsCommonStock	14211000	USD
CY2015Q1	us-gaap	Dividends Common Stock DividendsCommonStock	23216000	USD
CY2014Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	2561000	USD
CY2015Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	2561000	USD
CY2014Q4	us-gaap	Due From Affiliates DueFromAffiliates	0	USD
CY2015Q1	us-gaap	Due From Affiliates DueFromAffiliates	0	USD
CY2014Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	USD
CY2015Q1	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2014Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	82812000	USD
CY2015Q1	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	82815000	USD
CY2014Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-22134000	USD
CY2015Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5853000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8003000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-7321000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	19439000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2086000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4988000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2152000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3206000	USD
CY2014Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	1202000	USD
CY2015Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	599000	USD
CY2014Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2015Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2014Q1	us-gaap	Investments In And Advances To Affiliates At Fair Value Period Increase Decrease InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease	0	USD
CY2014Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	374028	shares
CY2014Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	11134000	USD
CY2015Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	13880000	USD
CY2014Q1	us-gaap	Interest Paid InterestPaid	7219000	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	16761000	USD
CY2014Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	13200000	USD
CY2015Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	9000000	USD
CY2015Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	257282000	USD
CY2014Q4	us-gaap	Investments Investments	251583000	USD
CY2015Q1	us-gaap	Investments Investments	258346000	USD
CY2015Q1	us-gaap	Investments In And Advances To Affiliates At Fair Value Period Increase Decrease InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease	0	USD
CY2014Q4	us-gaap	Land Land	193793000	USD
CY2015Q1	us-gaap	Land Land	193793000	USD
CY2014Q4	us-gaap	Land Improvements LandImprovements	3646000	USD
CY2015Q1	us-gaap	Land Improvements LandImprovements	3646000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	1123069000	USD
CY2015Q1	us-gaap	Liabilities Liabilities	1072343000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2064892000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2004497000	USD
CY2014Q4	us-gaap	Line Of Credit LineOfCredit	68000000	USD
CY2015Q1	us-gaap	Line Of Credit LineOfCredit	26000000	USD
CY2015Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	240363000	USD
CY2014Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	200000000	USD
CY2015Q1	us-gaap	Loans Payable To Bank LoansPayableToBank	200000000	USD
CY2014Q4	us-gaap	Loans Receivable Net LoansReceivableNet	235176000	USD
CY2015Q1	us-gaap	Loans Receivable Net LoansReceivableNet	241132000	USD
CY2015Q1	us-gaap	Long Term Debt LongTermDebt	1049325000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	808687000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	3284000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	229182000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3083000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2987000	USD
CY2015Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	2102000	USD
CY2015Q1	us-gaap	Longterm Debt Percentage Bearing Variable Interest Amount LongtermDebtPercentageBearingVariableInterestAmount	200000000.0	USD
CY2014Q4	us-gaap	Longterm Debt Percentage Bearing Variable Interest Amount LongtermDebtPercentageBearingVariableInterestAmount	200000000.0	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	-43000	USD
CY2015Q1	us-gaap	Minority Interest MinorityInterest	-54000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	126910000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-76086000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-128139000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6237000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1207000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24701000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-7303000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	19450000	USD
CY2014Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-18000	USD
CY2015Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-11000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9864000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	16889000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	2122812000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	131801000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Five Years OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears	196153000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	190603000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	185745000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	180904000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	1237606000	USD
CY2014Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	36093000	USD
CY2015Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	49505000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1545000	USD
CY2014Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-70000	USD
CY2015Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-113000	USD
CY2014Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	300000	USD
CY2015Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-100000	USD
CY2014Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	16597000	USD
CY2015Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	25672000	USD
CY2014Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	9873000	USD
CY2015Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	130000	USD
CY2014Q1	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	56000	USD
CY2015Q1	us-gaap	Payments To Acquire Furniture And Fixtures PaymentsToAcquireFurnitureAndFixtures	675000	USD
CY2014Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	5000	USD
CY2015Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	311000	USD
CY2014Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	19428000	USD
CY2015Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	7303000	USD
CY2014Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	108650000	USD
CY2015Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	0	USD
CY2015Q1	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	0	USD
CY2013Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.07125
CY2014Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2561000	USD
CY2015Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2561000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q1	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	25.00
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5750000	shares
CY2015Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5750000	shares
CY2013Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5800000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5750000	shares
CY2015Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5750000	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	58000	USD
CY2015Q1	us-gaap	Preferred Stock Value PreferredStockValue	58000	USD
CY2014Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	USD
CY2015Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	2052000	USD
CY2014Q1	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	USD
CY2015Q1	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	USD
CY2014Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	219100000	USD
CY2014Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	160600000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-648000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-7587000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	138300000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	350000000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	USD
CY2014Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	46103000	USD
CY2015Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2014Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2015Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2014Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	26500000	USD
CY2015Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-42000000	USD
CY2014Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2015Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1144000	USD
CY2014Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	185994000	USD
CY2015Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	199767000	USD
CY2014Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1831799000	USD
CY2015Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1832474000	USD
CY2014Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1645805000	USD
CY2015Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1632707000	USD
CY2014Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	57325000	USD
CY2015Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	697000	USD
CY2014Q1	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	211250000	USD
CY2015Q1	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7024000	USD
CY2015Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6948000	USD
CY2014Q1	us-gaap	Revenues Revenues	40850000	USD
CY2015Q1	us-gaap	Revenues Revenues	55572000	USD
CY2013Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	25.00
CY2014Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	28.35
CY2014Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	24.25
CY2014Q4	us-gaap	Secured Debt SecuredDebt	124022000	USD
CY2015Q1	us-gaap	Secured Debt SecuredDebt	123325000	USD
CY2014Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	400000	USD
CY2015Q1	us-gaap	Security Deposit Liability SecurityDepositLiability	400000	USD
CY2014Q4	us-gaap	Senior Notes SeniorNotes	700000000	USD
CY2015Q1	us-gaap	Senior Notes SeniorNotes	700000000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2513000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2918000	USD
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2015Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	4700000	shares
CY2014Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	8100000	shares
CY2014Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6900000	shares
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	941866000	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	932208000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	460164000	USD
CY2014Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	438723000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	941823000	USD
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	932154000	USD
CY2014Q1	us-gaap	Straight Line Rent StraightLineRent	4186000	USD
CY2015Q1	us-gaap	Straight Line Rent StraightLineRent	5656000	USD
CY2014Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	0	USD
CY2015Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	-1545000	USD
CY2014Q4	us-gaap	Unsecured Debt UnsecuredDebt	699272000	USD
CY2015Q1	us-gaap	Unsecured Debt UnsecuredDebt	699298000	USD
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38968403	shares
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59559253	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38968403	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59185225	shares
CY2015Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001492298-15-000017-index-headers.html	Edgar Link	pending
0001492298-15-000017-index.html	Edgar Link	pending
0001492298-15-000017.txt	Edgar Link	pending
0001492298-15-000017-xbrl.zip	Edgar Link	pending
ex101form_leasexamendment.htm	Edgar Link	pending
ex102form_guaranty.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sbra-20150331.xml	Edgar Link	completed
sbra-20150331.xsd	Edgar Link	pending
sbra-20150331_cal.xml	Edgar Link	unprocessable
sbra-20150331_def.xml	Edgar Link	unprocessable
sbra-20150331_lab.xml	Edgar Link	unprocessable
sbra-20150331_pre.xml	Edgar Link	unprocessable
sbra10q2015q1.htm	Edgar Link	pending
sbraex1212015q1.htm	Edgar Link	pending
sbraex3112015q1.htm	Edgar Link	pending
sbraex3122015q1.htm	Edgar Link	pending
sbraex3212015q1.htm	Edgar Link	pending
sbraex3222015q1.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

2015 Q1 Form 10-Q Financial Statement

#000149229815000017 Filed on May 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA Sabra Health Care REIT, Inc. Stock $sbra

2015 Q1 Form 10-Q Financial Statement

#000149229815000017 Filed on May 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra